Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells  by Pastrana, Erika et al.
Cell Stem Cell
Protocol ReviewEyes Wide Open: A Critical Review
of Sphere-Formation as an Assay
for Stem CellsErika Pastrana,1,2,3 Violeta Silva-Vargas,1,2 and Fiona Doetsch1,*
1Departments of Pathology and Cell Biology, Neurology, and Neuroscience, Columbia Stem Cell Initiative,
Center for Motor Neuron Biology and Disease, Columbia University Medical Center, New York, NY 10032, USA
2These authors contributed equally to this work
3Present address: Nature Publishing Group, New York, NY 10013, USA
*Correspondence: fkd2101@columbia.edu
DOI 10.1016/j.stem.2011.04.007
Sphere-forming assays have been widely used to retrospectively identify stem cells based on their reported
capacity to evaluate self-renewal and differentiation at the single-cell level in vitro. The discovery of markers
that allow the prospective isolation of stem cells and their progeny from their in vivo niche allows the func-
tional properties of purified populations to be defined. We provide a historical perspective of the evolution
of the neurosphere assay and highlight limitations in the use of sphere-forming assays in the context of neu-
rospheres. We discuss theoretical and technical considerations of experimental design and interpretation
that surround the use of this assay with any tissue.Stem cells are remarkable cells that are found in many tissues.
They exhibit two cardinal properties: the ability to undergo self-
renewal and the ability to differentiate. Because of these proper-
ties, stem cells are of crucial importance for maintaining tissue
homeostasis and for tissue repair after injury. Great excitement
has arisen about the therapeutic potential of stem cells, as well
as recognition of their contribution to pathological states such
as tumors. Changes in stem cell properties and the niches they
inhabit may also have profound consequences for under-
standing aging.
To explore the dynamics, function, and regulation of stem cells
and how these may go awry in disease, experimental assays
must reliably be able to distinguish stem cells and their progeny.
Due to the general lack of unique cell-surface markers and the
absence of a distinct and discernable morphological phenotype,
stem cells have typically been defined and studied on the basis
of functional criteria.
With the development of markers to prospectively identify
putative stem cells, as well as sophisticated genetic approaches
for lineage tracing, it is becoming increasingly feasible to define
the dynamics of stem cells in vivo. Moreover, the ability to
prospectively purify stem cells and their progeny has allowed
their functional properties to be studied in vitro and their potential
to be evaluated by transplantation in vivo. In the last few years,
exciting discoveries have been made about the existence of
quiescent and activated pools of stem cells and their ability to
shuttle between these states. Transit amplifying progeny also
have the potential to revert back to a stem cell state, at least in
some tissues. As we discover more about the biology and
behavior of stem cells within their niches and novel principles
emerge, it is important to re-evaluate the strategies utilized to
identify and functionally characterize adult stem cells. In partic-
ular, it is crucial to distinguish whether different paradigms eval-
uate actual in vivo stem cells or reveal stem cell potential and to486 Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc.have a clear understanding of the strengths and limitations of
different assays.
Stem cells from diverse tissues are typically cultured in vitro
under nonadherent conditions as spheres, or under adherent
conditions in two-dimensional cultures or in three-dimensional
matrices. Sphere-forming assays are widely used in stem cell
biology, as theoretically both self-renewal and differentiation
can be evaluated at the single-cell level. In this Protocol Review,
we critically assess the utility and the limitations of sphere-form-
ing assays. As they were first used in the neural stem cell field
almost 20 years ago, we provide a historical overview of the
evolution of the neurosphere assay, which highlights important
lessons that have been learned in the neural stem cell field
regarding the identity of neurosphere-forming cells. Indeed,
not all neurospheres arise from stem cells, and this finding criti-
cally impacts the broadly held premise that sphere-forming
assays are a functional assay for uniquely detecting in vivo
stem cells. Instead, sphere-forming assays evaluate the poten-
tial of a cell to behave as a stemcell when removed from its in vivo
niche. We then outline additional important theoretical and tech-
nical considerations that incorporate emerging principles in stem
cell biology that impact the interpretation of sphere-forming
assays when used to evaluate stem cells from any organ.
The Neurosphere Assay: A Historical Perspective
The discovery of adult neural stem cells was the result of two
coincident and divergent lines of research. The first was the
reinvestigation of adult neurogenesis, and the second was the
in vitro study of multipotent precursors from the adult brain.
Neural stem cells present in specialized niches in the adult
mammalian brain continuously generate new neurons that are
functionally integrated into neural circuits, including in humans.
Adult neurogenesis occurs in two regions of the mammalian
brain: the subventricular zone (SVZ), which is a thin layer of
Figure 1. Schema of the Neurosphere
Assay
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olfactory bulb interneurons, and the subgranular zone (SGZ) in
the hippocampal formation. These areas of continuous neuro-
genesis harbor stem cells that retain the capacity to proliferate,
self-renew over an extended period of time, and differentiate
into the three primary cell types of the brain (neurons, astrocytes,
and oligodendrocytes). As the neurosphere assay is almost
exclusively used in the SVZ and not the SGZ, from which cells
are predominantly cultured as adherent cells, the rest of this
review is focused on the SVZ.
In the late 1960s, Joseph Altman first showed that new
neurons are generated in the adult mammalian brain, yet this
finding was largely ignored (Altman, 1969). In the 1980s, the
group of Fernando Nottebohm showed that new neurons
functionally integrate into the adult songbird brain (reviewed in
Nottebohm, 2004). However, it was not until the early 1990s,
when new technical approaches were utilized combining
in vivo labeling and in vitro culture, that it was shown that precur-
sors capable of giving rise to neurons were present in the adult
mammalian brain and that neurogenesis and long-distance
migration occur in vivo (Lois and Alvarez-Buylla, 1993, 1994;
Kirschenbaum and Goldman, 1995).
At the same time, Reynolds and Weiss first cultured cells that
exhibit stem cell properties as free-floating spheres, called
neurospheres, from the adult brain (Reynolds and Weiss,
1992). They dissected striatal tissue, which included the periven-
tricular area encompassing the SVZ, enzymatically dissociated
the tissue to single cells and plated them in nonadherent condi-
tions in serum-free medium in the presence of epidermal growth
factor (EGF) (Figure 1). A small population of cells began to
divide, initially adhering to the plate, and after a few days,
detaching and forming spheres of proliferating cells. Themajority
of cells within these neurospheres expressed nestin, an interme-
diate filament present in neuroepithelial stem cells in the
embryonic brain. To assess whether cells could be propagated
as secondary cultures, to show self-renewal, the neurospheres
weremechanicallydissociatedandculturedagain in thepresenceCell Stem Cof EGF, with a subset forming secondary
neurospheres (Figure 1). When plated on
an adherent substrate, they differentiated
into both neurons and glial cells. This
provided the first evidence that multi-
potent stemcellswere present in the adult
mammalian brain.
Microdissection experiments subse-
quently revealed that the SVZ (also
called the subependymal zone) is the
source of neurospheres in vivo (Mors-
head et al., 1994). Moreover, it was
also proposed that neurospheres only
arise from relatively quiescent cells
in vivo, based on a series of [3H]-thymi-
dine kill experiments, in which neuro-
spheres were cultured after the in vivoelimination of rapidly dividing cells (Morshead et al., 1994).
However, as the cell types in the SVZ had not yet been defined,
it was not clear which cells were present when neurospheres
were cultured at different time points after the [3H]-thymidine
kill. Further experiments revealed that neurospheres can be
cultured from the entire ventricular axis of the central nervous
system, including the spinal cord (Weiss et al., 1996; Vescovi
et al., 1993). However, both bFGF and EGF are required for
neurospheres to grow from these non-neurogenic brain regions.
EGF neurospheres can only be cultured from the SVZ.
Since these early experiments, the neurosphere assay has
evolved. It is now accepted that the assay needs to be performed
at clonal density. To demonstratemultipotency, individual neuro-
spheres must give rise to neurons, astrocytes, and oligodendro-
cytes, the three main cell types in the brain, upon differentiation
after withdrawal of growth factors. In addition, although at first
neurospheres were considered to be a homogeneous population
of nestin+ stem cells, it is now clear that individual neurospheres
contain stem cells, progenitors, and differentiated cells.
The neurosphere assay therefore appeared to provide a simple
retrospective assay to identify cells exhibiting both functional
properties of stem cells, self-renewal, and differentiation, as
well as a quantitative readout of the number of stem cells in vivo.
Importantly, the identity of the in vivo stem cells had not yet been
discovered, and it was not feasible to prospectively isolate
different cell populations from the SVZ to directly test which cells
have the capacity to give rise to neurospheres.
Anatomy of the SVZ and Identity of Stem Cells
A key step in identifying the stem cells responsible for adult neu-
rogenesis, determining their in vivo lineage, and elucidating
which cells give rise to neurospheres was defining the cell
types and architecture of the SVZ niche. The SVZ has several
striking organizational features, best visualized in whole-mount
preparations that reveal the entire three-dimensional surface of
the ventricular wall (Doetsch and Alvarez-Buylla, 1996). It has
recently been shown that stem cells in the adult SVZ areell 8, May 6, 2011 ª2011 Elsevier Inc. 487
Figure 2. SVZ Anatomy and Lineage
(A) Frontal schema of adult mouse brain showing
SVZ in orange adjacent to the lateral ventricle.
(B) Summary schema of the organization of SVZ
cells. GFAP+ stem cells (B, blue), transit-ampli-
fying cells (C, green), neuroblasts (A cells, red), are
adjacent to ependymal cells (E, gray), which line
the lateral ventricle (LV). A subset of GFAP+ cells
(B1) extend a process between ependymal cells to
contact the LV. GFAP+ B2 cells are located closer
to the vasculature and divide more frequently.
Stem cells and transit-amplifying cells directly
contact the vasculature at specialized regions on
blood vessels lacking astrocyte endfeet (dark
blue) and pericyte coverage (yellow) (Modified
from Tavazoie et al., 2008).
(C) Confocal image of ependymal cell pinwheel
with GFAP::GFP+ Type B1 cell contacting the
ventricle at its center (Image from A. Maldonado-
Soto, generated according to the methods re-
ported in Mirzadeh et al., 2008).
(D) Stem cell lineage and sagittal schema of adult
mouse brain showing whole-mount perspective of
SVZ adjacent to lateral ventricle (red). Newly
generated neurons migrate along the rostral
migratory stream (RMS) to the olfactory bulb (OB).
Small numbers of oligodendrocytes are also
generated in the SVZ, but are not shown here.
Beige block indicates neurosphere-forming cells
in the lineage.
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subtypes reside in different regions (Hack et al., 2005; Merkle
et al., 2007; Young et al., 2007; Kelsch et al., 2007; Ventura
and Goldman, 2007). Newly generated neurons migrate from
their sites of birth and collect in a network of migrating chains
that extends throughout the SVZ to join the rostral migratory
stream that leads to the olfactory bulb (Doetsch and
Alvarez-Buylla, 1996). A small number of oligodendrocytes are
also generated in the adult SVZ (Nait-Oumesmar et al., 1999;
Menn et al., 2006). However, it is still unknown if tripotent stem
cells exist in vivo or whether separate stem cells give rise to
oligodendrocytes and neurons.
Initially, ultrastructural analysis was used to identify the cellular
populations in the SVZ, as there were no markers available to
distinguish the different cell types (Doetsch et al., 1997). Indeed,
two markers commonly used to identify neural stem cells, nestin
and Sox2, are expressed by all cell types in this region and,
therefore, cannot be used as unique markers of stem cells
(Doetsch et al., 1997; Tavazoie et al., 2008). Four main classes
of cells are present in the SVZ (Figure 2). Multiciliated ependymal
cells (Type E cells) line the ventricles. The chains of neuroblasts
(Type A cells) travel through tunnels formed by the processes of
glial fibrillary acidic protein (GFAP)+ cells with many ultrastruc-
tural features of astrocytes (Type B cells). Rapidly dividing
transit-amplifying cells (Type C cells) are clustered adjacent to
the chains of neuroblasts.
Cell ablation and lineage-tracing studies established the SVZ
stem cell lineage. Intriguingly, cells with several hallmarks of glial
cells, long thought to be support cells in the brain and derived
from a completely different lineage than neurons, are stem cells
in both adult neurogenic regions (reviewed in Kriegstein and
Alvarez-Buylla, 2009). Within the SVZ, GFAP-positive (Type B)
cells are stem cells both during regeneration and under homeo-
stasis (Doetsch et al., 1999a). They divide to generate transit488 Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc.amplifying cells, which in turn give rise to neuroblasts (Figure 2).
Furthermore, a subset of GFAP+ cells form neuropheres. At the
time that GFAP+ cells were identified as stem cells, ependymal
cells were also proposed to be stem cells in the SVZ (Johansson
et al., 1999). This debate was largely resolved as more sophisti-
cated genetic labeling and purification strategies were devel-
oped. This finding was not replicated by others (reviewed in
Kokovay et al., 2008), and the original groupproposing that epen-
dymal cells form neurospheres has recently published that they
do not give rise to neurons under homeostasis (Carle´n et al.,
2009). However, several recent papers have resurrected the
idea that multiciliated ependymal cells are stem cells, based on
the claim that CD133 and FoxJ1 are exclusively expressed by
ependymal cells and can be used to purify them (Coskun et al.,
2008; Meletis et al., 2008). However, both markers are also
expressed by a subpopulation of GFAP+ cells (see below); the
specificity of these markers in non-neurogenic brain regions
needs to be better defined using high resolution ultrastructural
and molecular analysis. Later experiments in which dividing
GFAP+ cells were killed in GFAP-TK mice confirmed that
GFAP+ cells are the source of adult generated neurons (Garcı´a
et al., 2004; Imura et al., 2003; Morshead et al., 2003). However,
even now, a critical issue is the lack ofmarkers available to distin-
guish between GFAP+ stem cells and other brain astrocytes, as
well as how they differ in their functional roles and potential.
Another important, and ongoing issue, is the identity and
dynamics of putative quiescent stem cells in the adult SVZ.
Based on regeneration studies, a pool of slowly dividing B cells
escapes being killed by an anti-mitotic drug and rapidly regener-
ates the SVZ (Doetsch et al., 1999a). Markers have not yet been
defined that allow the purification of these quiescent cells. More-
over it is still unknown whether these cells are only activated
during injury or whether a deeply quiescent pool participates in
neurogenesis under homeostasis as well.
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to Neurosphere-Forming Cells
A crucial advance in defining which cells form neurospheres was
the identification of markers that allow populations at different
stages of the lineage to be isolated or killed using genetic
approaches.
Heterogeneity of GFAP+ Type B Cells
A very active effort in the neural stem cell field is to define the
heterogeneity of GFAP+ cells within the SVZ and elsewhere in
the brain and assess their stem cell potential. Important insights
have arisen from anatomical, ultrastructural, and functional
analysis.
Early studies using electronmicroscopy identified two popula-
tions of GFAP+ Type B cells in the SVZ. Type B1 cells extend
a process between ependymal cells to contact the lateral
ventricle and have a primary cilium (Doetsch et al., 1999b).
Type B2 cells are located closer to the vasculature and divide
more frequently (Doetsch et al., 1997) (Figure 2). Recent work
has uncovered important new features of the SVZ niche (Mirza-
deh et al., 2008; Shen et al., 2008; Tavazoie et al., 2008), which
sheds light on the functional organization of GFAP+ Type B cells.
Ependymal cells are organized as a series of pinwheels along the
ventricular wall with Type B1 astrocytes contacting the ventricle
at the center of these pinwheels (Mirzadeh et al., 2008) (Figure 2).
In addition, a planar vascular plexus extends throughout the
length of the SVZ (Shen et al., 2008; Tavazoie et al., 2008).
Both stem cells and transit-amplifying cells are tightly associated
with this vascular plexus and contact it at specialized sites that
lack astrocyte endfeet (Shen et al., 2008; Tavazoie et al., 2008).
Several markers have now been identified that distinguish
different subpopulations of Type B cells in the SVZ and have
allowed their prospective purification (Pastrana et al., 2009;
Beckervordersandforth et al., 2010). Importantly, some of these
markers are coexpressed by multiple cell types, such as CD133
(prominin), which is expressed by both ependymal cells and a
subset of B1 cells contacting the ventricle (Coskun et al., 2008;
Mirzadeh et al., 2008; Beckervordersandforth et al., 2010). At
least four populations of GFAP-expressing B cells can be dis-
cerned within the SVZ: Type B1 cells contacting the ventricle
(Doetsch et al., 1999b;Mirzadeh et al., 2008; Beckervordersand-
forth et al., 2010), some of which express CD133 (prominin);
actively dividing (activated) EGFR+ astrocytes, some of which
contact the lateral ventricle (Doetsch et al., 2002; Pastrana
et al., 2009) and non-dividing multipolar niche astrocytes found
closest to the striatum (Garcı´a et al., 2004; Mirzadeh et al.,
2008; Shen et al., 2008). The overlap of marker expression,
proliferation state and morphology of these different subpopula-
tions still needs to be elucidated.
Multiple Populations Give Rise to Neurospheres
Until recently, adult neural stem cells and their progeny have
been difficult to purify using fluorescence-activated cell sorting
(FACS) due to the lack of markers that allow separation of cells
at different stages in the lineage and direct comparison of
their neurosphere-forming capacity. Diverse approaches have
been used to attempt to isolate adult neural stem cells and
their progeny, based on markers for cells at different stages in
the lineage, cell-cycle status, and putative general stem cell
markers, including metabolic substrates, dye efflux, surface
markers, fluorescently-complexed molecules, and transgenicreporter mice (Table 1 and references therein). Table 1 summa-
rizes the neurosphere formation efficiency of adult cells purified
using different strategies. Interestingly, the side population
purification method, in which Hoechst exclusion is used to
prospectively isolate stem cells (reviewed in Golebiewska
et al., 2011), is not selective for neurosphere-forming cells (Kim
and Morshead, 2003). Similarly, aldehyde dehydrogenase
activity does not significantly enrich for neurosphere-forming
cells (Corti et al., 2006; Obermair et al., 2010).
Some combinations of markers have allowed significant
enrichment of neurosphere-forming cells from the adult SVZ
(Table 1). However, most of the markers employed in these
studies are common to several stages in the lineage and yield
mixedpopulationsof neural progenitor cells.When combinations
of markers are used that allow the simultaneous isolation of
different stages of the lineage and the neurosphere-forming
capacity of each population assessed, it has become clear that
neurospheres arise from cells within the lineage that express
EGFR and are in a proliferative state (activated GFAP+ stem cells
and transit-amplifying cells) (Table 1; Doetsch et al., 2002;
Pastrana et al., 2009). Consistent with these findings, killing of
transit-amplifying cells and dividing GFAP+ cells greatly reduces
neurosphere formation (Doetsch et al., 2002; Garcı´a et al., 2004;
Imura et al., 2003; Morshead et al., 2003). Both populations can
be serially passaged and are multipotent. As such, the neuro-
sphere assay does not provide an accurate readout of the
number of stem cells in vivo. Moreover, the neurosphere assay
likely does not detect quiescent stem cells, as the purified popu-
lation containing putative quiescent stem cells does not give rise
to neurospheres (Pastrana et al., 2009). The identification of
markers that allow the isolation of quiescent stem cells will allow
their sphere-forming capacity to be directly tested. Defining the
populations of cells that form neurospheres after injury in various
models will also be important to pinpoint potential latent stem
cells elsewhere in the brain (Robel et al., 2011). It will be important
to assess the long-term self-renewal capacity of different purified
populations that can give rise to neurospheres both in vitro and
after transplantation in vivo (Neumeister et al., 2009).
As revealed by this historical overview, the neurosphere assay
cannot be used alone to define the in vivo stem cells. However, if
performed carefully, it can provide a useful tool to assay stem
cell potential in vitro in a relatively simple manner. Sphere-form-
ing assays are increasingly used, both retrospectively and
prospectively, to investigate stem cells and progenitors in
many tissues during development and in the adult (Table 2), as
well as in cancers and the cancer stem cell field (Hirschhaeuser
et al., 2010; Clevers, 2011). Similarly, they are frequently
employed to dissect the molecular regulation of self-renewal
and differentiation and to investigate how the intrinsic properties
of stem cells and progenitors change with aging and pathology.
For the appropriate interpretations of such experiments, it is
essential to understand the strengths and limitations of this
assay. Below, we highlight critical considerations for sphere-
forming assays that are relevant for all systems.
Critical Considerations for Sphere-Forming Assays
Over the years, experimental variability has been introduced
into sphere-forming assays including medium composition and
volume, cell density, surface area of the culture dish and durationCell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc. 489
Table 1. Markers Used to Purify Neurospheres from the Adult Brain and Their Reported Efficiencies
Marker Isolation Strategy Reported % NS formation from Adult Reference
Bulk frequency bulk dissociated cells 0.03%–1%
Aldehyde dehydrogenase ALDH activity with aldefluor substrate 2.82% Corti et al. (2006)
Cell size/PNA/CD24 cells > 12mm/ anti-PNAlo cells/ anti-CD24lo 80% Rietze et al. (2001)
CD15 (Lex, SSEA-1)
or CD24
anti-CD15 or anti-CD24 CD15+ 25%
CD24+ 0.15%
Capela and Temple (2002)
CD133 (Prominin) anti-CD133 4% Corti et al. (2007)
CD133 or CD24 anti CD133 or anti-CD24 CD133+ 6%
CD24+ 0.9%
Coskun et al. (2008)
CD133/CD24 anti CD133/anti-CD24 CD133+/CD24+ 0% Pfenninger et al. (2011)
CD133/CD15/aldehye
dehydrogenase
anti-CD133/anti-CD15/aldehyde
dehydrogenase activity
with aldefluor substrate
CD15+ 0.45%
Aldhhi 0.41%
Aldhhi/CD15+ 0.24%
did not detect
CD133+/CD15+ cells
Obermair et al. (2010)
Dcx Dcx::GFP Dcxlo 0.8%
Dcx 1.2%
Walker et al. (2007)
Dlx2/CD24 Dlx2::LacZ/Anti-CD24 Dlx2+CD24 14% Doetsch et al. (2002)
Dil labeling (intraventricular
injection)
intraventricular injection of DiI Dil+ 6.2% Johansson et al. (1999)
Erythroagglutinin
lectin (E-PHA)
FITC conjugated E-PHA Low E-PHA 0.02%
High E-PHA 0.26%
Hamanoue et al. (2009)
FGF1B F1B::GFP 1% Hsu et al. (2009)
GFAP GFAP-GFP adenoviral labelling 11.65% Doetsch et al. (1999a)
GFAP/EGFR/CD24 hGFAP::GFP/Fluorescent
EGF ligand/anti-CD24
GFP+EGFR+CD24+ 30%
EGFR+ 7.5%
CD24lo 0%
GFP+ 0%
Pastrana et al. (2009)
GFAP/CD133 hGFAP::GFP/antiCD133 78% Beckervordersandforth
et al. (2010)
Id1 reporter activity Id1::GFP Id1GFPhi 1%
Id1GFPlo 0.5%
Nam and Benezra (2009)
Mcm2 Mcm2::GFP 3% Maslov et al. (2007)
Nestin Nestin::GFP 0.30% Kawaguchi et al. (2001)
Notch 1 anti-Notch1 Notch1+ 2.8% Johansson et al. (1999)
Notch reporter activity TNR::EGFP EGFPhi 70%
EGFPlo10%
Andreu-Agullo´ et al. (2009)
Side population (SP) exclusion of Hoechst 33342 SP 2.1%
Non-SP 0.28%
Kim and Morshead (2003)
Sox1 Sox1::GFP 1.70% Barraud et al. (2002)
Sox2/beta1 integrin sox2::GFP/ beta1 integrin Sox2GFP+beta1+ 0.05%
Sox2GFP+beta1 47%
Kazanis et al. (2010)
Selective Killing Experiments
DLX2 Dlx2-TK 70% of ns are killed Doetsch et al. (2002)
GFAP GFAP-TK 100 % of ns are killed Imura et al. (2003);
Morshead et al. (2003);
Garcı´a et al. (2004)
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2006). This diversity in protocols has favored differing and some-
times conflicting results to arise fromdifferent groups. In Figure 3,
we outline the steps and critical experimental parameters that
are crucial in the design and execution of sphere assays. Below,
we highlight general issues that are essential for the interpreta-
tion of sphere-forming assays (Table 3).490 Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc.Cell Density and Clonality of Spheres
Cell density is the most important and controversial parameter
of sphere-forming assays because it has a critical impact on
clonality. The final readout of sphere-forming assays is the size
and number of spheres, whether primary or passaged. A central
tenet of sphere-forming assays is that each sphere is derived
from a single cell and is therefore clonal.
Table 2. Tissues in which Sphere-Forming Assays Have Been
Used
Tissue Isolation Markers References
Breast human bulk breast tissue;
Lin (CD45/CD31/Ter119)/
CD29/CD24
Dontu et al. (2003)
Shackleton et al. (2006)
Cornea bulk microdissected human
corneal epithelium
Yokoo et al. (2005)
Dermis bulk skin tissue Toma et al. (2001)
Heart side population Tomita et al. (2005)
Pancreas bulk microdissected pancreatic
islets and ductal tissue;
ALDH1/ E-cadherin
Seaberg et al. (2004)
Rovira et al. (2010)
Pituitary
gland
side population Chen et al. (2005)
Prostate Lin (CD45/CD31/Ter119)/
Sca1/CD49f
Lawson et al. (2007)
Retina bulk microdissected ciliary
margin of outer retinal
pigmented epithelium
Tropepe et al. (2000)
Trachea KRT5-GFP; human bronchi:
Itga6/NGFR
Rock et al. (2009)
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clonal to much higher cell concentrations, are used in different
laboratories. Different groups consider a wide range of ratios
of cells per volume of tissue culture medium to be consistent
with a clonal density. Indeed, anywhere between 0.2 to 20 cells
per ml is considered—or at least named—appropriate for clonal
conditions of growth (Coles-Takabe et al., 2008; Ferro´n et al.,
2007; Chojnacki and Weiss, 2008). Results obtained from high
density seeded cultures are impossible to interpret due to fusion
of spheres. Even low-density cultures can be problematic.
Mixing experiments in which wild-type and fluorescently labeled
cells are cocultured suggest that a neurosphere can reliably be
of clonal origin only when cells are plated at 10 cells/ml or
1 cell/ml when using primary cells and passaged spheres,
respectively (Coles-Takabe et al., 2008). However, using imaging
approaches, neurospheres were observed to frequently aggre-
gate and fuse, even at low densities (Singec et al., 2006; Mori
et al., 2006). Indeed, time-lapse imaging experiments show
that free-floating neurospheres are highly dynamic structures
that undergo intrinsic, spontaneous locomotion (Singec et al.,
2006), even if left untouched in the incubator. A second major
cause of nonclonality is experimenter-induced aggregation
(Coles-Takabe et al., 2008). Movement of plates to examine
cultures under the microscope rapidly leads to the aggregation
of spheres at the center of the plate. As such, true clonality
can only be guaranteed by plating single cells per well.
Importantly, the choice of an appropriate cell density should
be determined by the intended purpose of the individual sphere
assay. If the experiment is designed to characterize and define
the stemcell potential (self-renewal and differentiation) of a newly
identified population in vitro, cells should be plated as single cells
per well to ensure clonality. However, it is important to note that
cell density directly impacts cell growth. Sphere-forming effi-
ciency decreases significantly when cells are plated as singlecells as compared to low-density conditions, due to autocrine/
paracrine signals released by cells into the medium. If the
purpose of the assay is to study other parameters, such as
survival or proliferation, it may be possible to use low-density
cultures, as long as it is recognized that spheres may not be
clonal. When spheres are passaged to assess self-renewal,
they should be replated at extremely low densities to avoid cell
fusion and aggregation.
It is also important to perform clonal density cultures even at
the primary sphere stage. Increasingly, primary spheres are
cultured at very high density and then, upon passaging, plated
at lower density. However, this practice can greatly impact the
interpretation of results. To reiterate, both primary and passaged
spheres should be cultured at clonal density. Finally, irregular
clumps of cells resulting from cell aggregation can also appear
in sphere cultures (Chen et al., 2005). For any stem cell system,
it should be validated that spheres actually arise from prolifera-
tion (such as by a short pulse of a nucleoside analog or by
time-lapse imaging) and are not simply the result of the aggrega-
tion of cells.
To circumvent some of the above technical hurdles, variations
of the classical sphere assay have recently been proposed.
Encapsulating spheres or culturing them in semiadherent condi-
tions (i.e., methylcellulose or collagen), similar to colony-forming
assays in the hematopoietic field (Purton and Scadden, 2007),
or microengineered hydrogel matrices may avoid problems
associated with experimenter-induced aggregation and intrinsic
mobility of spheres (Ignatova et al., 2002; Cordey et al., 2008;
Louis et al., 2008).
Sphere-Forming Assays May Not Detect Quiescent
Stem Cells
An important caveat of sphere-forming assays is that they may
not detect quiescent stem cells. Quiescent stem cells reside in
a G0 state, which likely prevents their depletion in vivo and the
possibility of the introduction of mutations during replication. In
contrast, sphere-forming assays predominantly allow the expan-
sion of cells that are either poised for proliferation in vivo or are
already actively dividing and can, therefore, be rapidly expanded
in vitro with mitogens. As such, it may never be feasible to detect
quiescent stem cells by sphere-forming assays, as the protocols
used do not provide as-yet-unknown key components of the
in vivo niche required for the activation of dormant stem cells,
either during homeostasis or after injury. In addition, the intrinsic
properties of quiescent stem cells may limit their rapid expansion
in the presence of growth factors, such as inherently slower cell-
cycle kinetics, and an intrinsic limitation on the number of times
they can divide before being exhausted. Once markers are
identified that allow quiescent stem cells to be purified directly
from their niche, insight will be gained into their physiology and
molecular regulation.
Sphere-Forming Assays Are Not a Read-Out
of In Vivo Stem Cell Frequency
Stem cell frequency is often calculated based on the number of
spheres generated from a given tissue sample. This premise is
based on the false assumption that all spheres are derived
from a stem cell. Indeed, as described above, FACS purification
of neural stem cells and their progeny have revealed that both
stem cells and their transit-amplifying progeny can give rise to
neurospheres. Furthermore, this pattern has also been observedCell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc. 491
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lost.   
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can affect cell behavior.  Serum is often used in collection tubes to increase 
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supplements for collection. Need protein in collection medium to provide a 
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•Perform acute immunostaining to assess heterogeneity of purified population 
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formation  
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Passaging  
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•Number of cells per ul should be reported  
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Figure 3. Flowchart Outlining Design and Critical Experimental Steps in Sphere-Forming Assays
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Protocol Reviewwith spheres that arise from isolated mammary populations,
termed mammospheres (Stingl, 2009). As such, sphere-forming
assays are not a read-out of in vivo stem cell activity, but instead
may reflect the potential of cells to exhibit stem cell traits.
Based on modeling of predicted and actual serial sphere-
forming capacity, it has been proposed that the neurosphere
assay overestimates stem cell frequency by an order of magni-
tude (Reynolds and Rietze, 2005). Less than 6%of cells in neuro-
spheres can be passaged more than seven times, suggesting492 Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc.that only a small fraction of cells exhibit extensive self-renewal
(Louis et al., 2008). These findings were all based on retrospec-
tive analysis of neurosphere formation. Indeed, it has become
common lore that serial passaging will eliminate more
committed progenitors and select for self-renewing stem cells.
However, both purified transit-amplifying cells from the adult
brain, which are short-lived cells in vivo, andmultipotent progen-
itors in breast can be serially passaged and retain multipotency
in vitro. Using prospectively purified populations, it will now be
Table 3. Overview of Critical Considerations for Sphere-Forming Assays
Cell density and clonality of spheres Cell density is critical parameter as it influences clonality. Spheres are prone to aggregation due
to both intrinsic locomotion and to experimenter-induced movement. Clonality is only
guaranteed by single cell plating. Important to ensure that spheres are due to proliferation of
cells and not to aggregation.
Sphere-forming assays may not detect
quiescent stem cells
Sphere forming assays predominantly detect cells that are poised for, or are actively
undergoing, proliferation. Quiescent cells may not be capable of forming spheres, either due to
intrinsic cell properties or due to lack of additional extrinsic signals needed for their activation in
this assay.
Sphere-forming assays are not a read-out of
in vivo stem cell frequency
Multiple populations in stem cell lineages, including both stem cells and transit amplifying cells,
are able to form spheres that can be serially passaged and are multipotent. The long-term
in vitro and in vivo potential of purified populations needs to be assessed.
Sphere size is not a read-out of
in vivo stem cells
Large spheres are often assumed to arise from stem cells. However, independent of
aggregation issues, sphere size simply reflects proliferation/ differentiation status and
responsiveness to growth factors of the parental clone-forming cell.
Towards the prospective purification
of sphere-forming cells
As FACS becomes an integral part of assaying the potential of different populations to form
spheres, it is essential to ensure that enzymatic digestion does not alter surface-marker profiles
(different enzymes result in markedly different surface profiles). In addition, the cell type
specificity of individual markers needs to be validated in vivo.
Markers are dynamic Purified populations reflect the state of a population at a given moment in time. Within a purified
population, cells may be in different states or stages of the cell cycle. Markers commonly used
to purify stem cells change their expression with the cell cycle. Cells can shuttle between
quiescent and activated states or from more committed to more primitive states.
Differentiation potential bias due to culture
with exogenous growth factors
Cells within a population may respond differently to distinct mitogens. Mitogens can also bias
the differentiation capacity of cells.
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Protocol Reviewimportant to determine whether there is a difference in the
number of times cells that were isolated at different stages can
be serially passaged in vitro. While sphere culture conditions
may allow long-term passaging of both cell types, this capacity
might not be the casewhen cells are exposed to the in vivo niche.
More challenging experimental conditions, such as transplanta-
tion paradigms or in vivo lineage tracing, are necessary comple-
ments of in vitro assays that will reveal differences in stem cell
behavior and potential.
Sphere Size Is Not a Read-Out of In Vivo Stem Cells
Significant heterogeneity exists in the size of individual spheres,
independent of the problem of merging, and it has been posited
that size indicates the nature of the founder clone. This premise
is confounded by nonuniform criteria regarding what sized
spheres to quantify, which typically ranges from 40–150 mm in
diameter. Stem cells are believed to give rise to large spheres,
and progenitors to smaller spheres. It has been postulated
that only large spheres can be serially passaged, as opposed
to smaller spheres, which cannot. However, this hypothesis
has not been rigorously tested with prospectively purified cells.
Indeed, the size of a sphere might also reflect responsiveness
to growth factors as well as the proliferation/differentiation
status of the parental clone-forming cell. This observation has
important implications for interpreting sphere size in loss-of-
function studies: smaller spheres could be a result of decreased
self-renewal, or altered responsiveness to growth factors.
Furthermore, the mode of division within a sphere can impact
the size of a sphere. For example, smaller neurospheres
(<100 mm) grown in leukemia inhibitory factor (LIF) give rise to
secondary neurospheres to the same extent as much larger
neurospheres grown with EGF alone (Bauer, 2009). This fact is
likely due to increased self-renewing divisions in the smallerspheres, and the presence of more differentiated cells in the
large spheres, which are incapable of being passaged. Thus,
large clones may actually contain fewer stem cells than smaller
clones.
Toward the Prospective Purification
of Sphere-Forming Cells
The ability to prospectively purify different populations of cells
and assess their in vitro and in vivo behavior is a crucial advance
in the stem cell field. Isolating stem and progenitor cells from
solid tissues presents unique challenges to obtaining a viable
single-cell suspension. Stem cells from solid tissues are often
relatively rare populations enmeshed in a complex extracel-
lular-rich microenvironment. As such, it is crucial to optimize
each isolation step to maximize yields (Figure 3). The use of
FACS to isolate cells from solid tissue has recently been re-
viewed elsewhere (Alexander et al., 2009). Particular care has
to be taken when FACS is used to isolate different populations,
as both the enzyme used and duration of digestion can
profoundly affect surface antigen survival, thereby influencing
marker expression. Indeed, the expression patterns of CD133,
CD15, and CD24 on embryonic neural progenitors are dramati-
cally different depending on whether trypsin, papain, collage-
nase/dispase or liberase 1 is utilized (Panchision et al., 2007),
with distinct populations of cells appearing and disappearing
depending on the enzyme. Asmore andmore complex combina-
tions of markers are used to FACS purify more refined popula-
tions of cells, this issue becomes increasingly important and
might explain conflicting results observed by various groups
that use different dissociation protocols. For example, it was
recently reported that CD133+GFAP::GFP+ cells contain all neu-
rosphere forming cells in the adult SVZ (Beckervordersandforth
et al., 2010). However, when papain is used, instead of trypsin,Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc. 493
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Protocol Reviewboth EGFR+GFAP::GFP+ and EGFR+-only cells give rise to
neurospheres (Pastrana et al., 2009). As such, it is crucial to
ensure that the profile observed by FACS matches the in vivo
expression pattern as well as to account for strain and species
differences.
Another key issue is to validate the specificity of markers
in vivo and to define the populations that express them. Some-
times it may be difficult to detect expression of a marker by
rare cells if it is highly expressed by more abundant cells. An
ongoing debate in the neural stem cell field is whether ependy-
mal cells are stem cells in the SVZ (Johansson et al., 1999;
Coskun et al., 2008). These claims are based on the putative
selective expression of markers on ependymal cells. Both
CD133 and FoxJ1 (Coskun et al., 2008; Meletis et al., 2008)
have been suggested to be exclusively expressed by ependymal
cells and have been used to purify them, followed by neuro-
sphere cultures. However, both markers are also expressed by
non-ependymal, GFAP+ (Type B1) cells, which are highly en-
riched for neurosphere forming potential (Mirzadeh et al., 2008;
Beckervordersandforth et al., 2010; Jacquet et al., 2009). This
overlap highlights how important it is to establish the specificity
of markers used to purify cells and assess their functional prop-
erties in vivo and in vitro.
A similar issue exists when labeling strategies are employed to
prospectively identify cells based on their anatomical localiza-
tion, for example, the injection of lipophilic dyes, such as DiI,
or of viruses encoding reporters, to label cells contacting
a lumen. It is essential to ensure that the tracer is not transferred
between cells and that all of the populations that contact the
lumen are known. In the brain, injection of tracers into the ventri-
cles will lead to the labeling of both ependymal cells and GFAP+
stem cells that contact the ventricle (Figure 2C), which initially led
to some confusion about the identify of neurosphere forming
cells.
Markers Are Dynamic
Purified populations remain heterogeneous, and the iterative
identification of additional markers will allow their further enrich-
ment. However, an important point to consider is that two
apparently distinct populations may actually be the same popu-
lation of cells that are in different states or stages of the cell
cycle. For example, the expression of Hes1, neurogenin2, and
Delta1, proteins that are classically thought to distinguish
various populations of cells in the developing brain, oscillates
within the same cell in a cell-cycle-dependent manner (Ka-
geyama et al., 2010). CD133, a marker frequently used to isolate
putative stem cells, is another example of a protein that is influ-
enced by the cell-cycle state (Sun et al., 2009). In vivo, CD133 is
expressed on primary cilia, yet in order to divide, cells must
disassemble the primary cilium, as the centriole in the basal
body is required for the centrosome. As such, these cells will
lose CD133 expression. Finally, two other recent findings have
important implications for the purification of different cells. An
emerging theme in stem cell biology is that cells can shuttle
between quiescent and activated states (Li and Clevers, 2010)
and that even more committed progenitors can revert back to
a more primitive state (Davies and Fuller, 2008), underscored
by the neutral drift that occurs in populations over time in
diverse stem cell systems (Lo´pez-Garcı´a et al., 2010; Snippert
et al., 2010).494 Cell Stem Cell 8, May 6, 2011 ª2011 Elsevier Inc.Differentiation Potential Bias Due to Culture
with Exogenous Growth Factors
Traditionally, spheres are cultured in high levels of growth
factors, in the presence of EGF (20 ng/ml), bFGF (10 ng/ml), or
both in many systems. Such high concentrations may bias
the differentiation potential of the cultured cells. For example,
standard culture conditions for neurospheres use high concen-
trations of EGF, which heavily biases the cells toward glial differ-
entiation, both in vitro and after transplantation in vivo. Lowering
the concentration of EGF promotes more neuronal differentia-
tion (Burrows et al., 1997), but the neural stem cell field
continues to use high levels of EGF in the medium. A second
key point is whether the same or different cells grow in the pres-
ence of different growth factors. With the advent of the ability to
purify different populations of cells by FACS, this issue can now
be addressed directly. An important question is whether the
multipotency observed in vitro also translates to the same set
of fates being adopted in vivo or whether this multipotent
capacity is only unmasked in the specific conditions present in
culture.
Alternatives to Sphere-Forming Assays
Modifications to sphere-forming assays have been developed
that circumvent some of the limitations described above. These
include bioengineering approaches using patterned substrates
to mimic the in vivo extracellular matrix and substrate elasticity,
adherent two-dimensional and three-dimensional cultures, such
as CFU assays, and coculture configurations with different niche
components (reviewed in Vunjak-Novakovic and Scadden,
2011). With any of these newer variants, it is important to assess
the behavior of purified populations in each assay.
An increasingly widely used assay in the neural stem cell field
is the neuronal colony-forming cell assay (Louis et al., 2008), in
which cells are cultured in a collagen-containing semi-solid
matrix with EGF and/or bFGF. This assay retrospectively defines
stem cells based on the size of the colony formed, with large
colonies over 1 to 2 mm in size postulated to be derived from
stem cells and all other smaller colonies from progenitors. This
assay is based on the premise that progenitor cells exhibit
limited proliferative capacity in relation to stem cells and that
the diameter of a colony can be used to distinguish its founder
cell type. It will be crucial to directly test this assumption using
purified populations of cells. While this assay circumvents the
issue of aggregation, it still suffers from several of the same limi-
tations of neurosphere assays, namely, dormant stem cells may
not divide to form large colonies, colony size may simply reflect
growth factor responsiveness, and the same biases of culturing
in high levels of growth factors.
Within a sphere, significant differentiation occurs due to
complex cell-cell interactions. Two-dimensional adherent
culture, in which stem cells and their progeny are expanded as
monolayers, significantly reduces the number of differentiated
cells during stem cell expansion. For example, culture of neural
stem cells as cell lines as a monolayer of adherent cells in the
presence of EGF and bFGF allows the propagation of a reason-
ably uniform population of cells with much less differentiation
than observed in nonadherent assays (Conti et al., 2005; Pollard
et al., 2009). However, this approach makes it more difficult
to monitor single clones. Another promising approach is the
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Protocol Reviewcoculture of purified stem cells with different ‘‘niche’’ cells in
the absence of additional growth factors, which provide more
physiological signals. Both endothelial cells and astrocyte cocul-
tures support the growth of neural stem cells (Lim and Alvarez-
Buylla, 1999; Malatesta et al., 2000; Song et al., 2002; Shen
et al., 2004; Cheng et al., 2009). An attractive feature of 2D
cultures is that morphological analysis and molecular character-
ization can easily be performed. Moreover, time-lapse imaging
of single colonies can reveal lineage dynamics of individual
cells (Qian et al., 1998; Scheffler et al., 2005; Cohen et al.,
2010; Costa et al., 2011).
Finally, three-dimensional Matrigel cultures have been very
powerful in providing a proper microenvironment for clonal
miniorgans to grow from single cells combined with other niche
cells (Sato et al., 2011). Such three-dimensional cultures may
constitute the ideal system to start assessing and manipulating
quiescent stem cells in vitro that have not yet been able to
grow in culture.Toward the Future
As our understanding of the in vivo biology of adult stem cells and
their niche deepens, it is crucial to develop new in vitro assays
that overcome the limitations and practical pitfalls of sphere-
forming assays and their modifications highlighted in this review.
These new assays will need to assess self-renewal and multipo-
tency at a clonal level without biasing cells by introducing satu-
rating levels of exogenous growth factors. Further development
of technologies, such as engineered culture matrices that allow
single-cell assays in both adherent and floating conditions, will
be an important step toward high-throughput assays that can
assess the role of different molecules on stem cell physiology.
In combination with increasingly sophisticated purification
methods, these studies will enable the rigorous comparison of
the biological differences between stem cells and their progeny.
It will be important for the community to extend and standardize
the use of these purificationmethods so that different assays can
be cross-compared and their effect on the different populations
better assessed. Importantly, stem cells cannot only be studied
in isolation. In addition to the development of 3D culture models
that recapitulate the in vivo niche, it will remain essential to
explore the biology of stem cell populations in vivo using trans-
plant paradigms and in vivo lineage tracing of endogenous pop-
ulations. Transplantation of purified stem cell populations or
cultured cells back into their endogenous niches can comple-
ment in vitro assays in evaluating the in vivo potential of these
populations. Moreover, serial transplantation studies could help
determine the self-renewal capacities of these cells. Great leaps
forward will continue to be made by the synergy between in vivo
and in vitro approaches, which mutually inform each other.ACKNOWLEDGMENTS
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